Pear Therapeutics (US)

Kirthiga Reddy

Ms. Reddy has served as a member of Pear’s board of directors since December 2021, is chair of the Nominating and Corporate Governance Committee, and a member of the Audit Committee. She previously served as a board observer on the Pear board from December 2020 through November 23, 2021. Ms. Reddy brings over 20 years of experience leading technology-driven transformations and is a cofounder of F7 Ventures, a female-led seed investment fund focused on enabling human operations and the investment themes of connected communities, future of work, and physical and mental health. Previously, she was a partner at SoftBank Investment Advisers (SBIA) from 2018 to 2021, where she focused on frontier, enterprise, and health technology investments. From July 2010 to March 2018, Ms. Reddy held various executive roles at Facebook, Inc (NASDAQ: FB). At Facebook, Ms. Reddy first served as the managing director for India and South Asia and subsequently focused on emerging and high-growth markets, including Mexico, Brazil, Indonesia, South Africa, and the Middle East. Additionally, Ms. Reddy has served as a member of the board of directors of several companies, including Collective Health, Inc since December 2019, where she also serves on the Compensation and Audit committees; WeWork Inc since February 2020; and Fungible, Inc since April 2021. Ms. Reddy has also served on the Investment Advisory Council for Neythri Futures Fund, a South Asian female-led stage-agnostic technology fund since March 2021. Ms. Reddy holds an MBA from Stanford University, an MS in computer engineering from Syracuse University, and a BE in computer science from Marathwada University, India. She served on the Stanford Business School Management Board from September 2014 to April 2019, including serving as chair from September 2018 to April 2019. She has been recognized as one of Fortune India’s “Most Powerful Women” and as Fast Company’s “Most Creative People in Business” among other recognitions.